Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Equity (2016 - 2025)

Historic Return on Equity for Assembly Biosciences (ASMB) over the last 10 years, with Q3 2025 value amounting to 0.38%.

  • Assembly Biosciences' Return on Equity rose 9600.0% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 9600.0%. This contributed to the annual value of 1.08% for FY2024, which is 900.0% down from last year.
  • Latest data reveals that Assembly Biosciences reported Return on Equity of 0.38% as of Q3 2025, which was up 9600.0% from 1.72% recorded in Q2 2025.
  • Assembly Biosciences' Return on Equity's 5-year high stood at 0.25% during Q1 2023, with a 5-year trough of 1.72% in Q2 2025.
  • Its 5-year average for Return on Equity is 0.88%, with a median of 0.67% in 2021.
  • In the last 5 years, Assembly Biosciences' Return on Equity plummeted by -11500bps in 2024 and then skyrocketed by 9600bps in 2025.
  • Quarter analysis of 5 years shows Assembly Biosciences' Return on Equity stood at 0.67% in 2021, then rose by 18bps to 0.55% in 2022, then tumbled by -167bps to 1.48% in 2023, then increased by 8bps to 1.35% in 2024, then soared by 72bps to 0.38% in 2025.
  • Its last three reported values are 0.38% in Q3 2025, 1.72% for Q2 2025, and 1.32% during Q1 2025.